Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 6, Pages 1511
Publisher
MDPI AG
Online
2020-06-24
DOI
10.3390/cells9061511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LncRNA XIST interacts with miR-454 to inhibit cells proliferation, epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer
- (2020) Xiaohua Li et al. JOURNAL OF BIOSCIENCES
- Deciphering the Mounting Complexity of the p53 Regulatory Network in Correlation to Long Non-Coding RNAs (lncRNAs) in Ovarian Cancer
- (2020) Sonali Pal et al. Cells
- The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma
- (2020) Xuejiao Chen et al. Biomolecules
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness
- (2019) Vivian Yvonne Shin et al. Cell Death & Disease
- The expanding roles of long non-coding RNAs in the regulation of cancer stem cells
- (2019) Zhaowu Ma et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Long noncoding RNA HOTAIR promotes invasion of breast cancer cells through chondroitin sulfotransferase CHST15
- (2019) Liang‐Chih Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression
- (2019) Jingjing Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA PTCSC3 inhibits triple‐negative breast cancer cell proliferation by downregulating lncRNA H19
- (2019) Ning Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
- (2019) Qingsong Hu et al. NATURE IMMUNOLOGY
- The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer
- (2019) Jian Zhang et al. Cell Death & Disease
- lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network
- (2019) Zijian Liu et al. Frontiers in Genetics
- Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition
- (2019) Jun-Ting Cheng et al. Cells
- Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness
- (2018) Hidetaka Shima et al. BREAST CANCER RESEARCH AND TREATMENT
- LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway
- (2018) Xiao-ming Wang et al. CANCER BIOLOGY & THERAPY
- Triple negative breast cancer in Asia: An insider’s view
- (2018) Chao Wang et al. CANCER TREATMENT REVIEWS
- LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway
- (2018) Zhigang Xiao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
- (2018) Liang Chang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Alarming Burden of Triple-Negative Breast Cancer in India
- (2018) Krishan K. Thakur et al. Clinical Breast Cancer
- Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer
- (2018) Kirsten M. Tracy et al. MOLECULAR CANCER RESEARCH
- Noncoding RNAs: Master Regulators of Inflammatory Signaling
- (2018) Chen Li Chew et al. TRENDS IN MOLECULAR MEDICINE
- Application of CRISPR/Cas9 for Long non-coding RNA genes in Cancer Research
- (2018) shuai zhen et al. HUMAN GENE THERAPY
- Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1 In Vivo
- (2018) Yu Wei Deng et al. Journal of Breast Cancer
- NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
- (2018) Di Huang et al. NATURE IMMUNOLOGY
- Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway
- (2018) Jiguang Han et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci
- (2018) Shaowei Wang et al. Cell Death & Disease
- Long Non-coding RNA Structure and Function: Is There a Link?
- (2018) Anna Zampetaki et al. Frontiers in Physiology
- LncRNA AWPPH promotes the growth of triple-negative breast cancer by up-regulating frizzled homolog 7 (FZD7)
- (2018) Kainan Wang et al. BIOSCIENCE REPORTS
- The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers
- (2018) Alex J. Gooding et al. ONCOGENE
- Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3
- (2018) Mayassa J. Bou-Dargham et al. PLoS One
- Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer
- (2018) Mª Luisa Pecero et al. CELLULAR ONCOLOGY
- A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability
- (2018) Mahdieh Jadaliha et al. PLoS Genetics
- Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis
- (2018) Muthu K. Shanmugam et al. Frontiers in Pharmacology
- Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy
- (2018) Meghan Leary et al. Cancers
- The Influence of Metabolism on Drug Response in Cancer
- (2018) Esther A. Zaal et al. Frontiers in Oncology
- Nanosoldiers: A promising strategy to combat triple negative breast cancer
- (2018) Akshayya Pawar et al. BIOMEDICINE & PHARMACOTHERAPY
- Do STAT3 inhibitors have potential in the future for cancer therapy?
- (2017) Andrea L.A. Wong et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling
- (2017) Xiaoming Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Mechanism of immune evasion in breast cancer
- (2017) Mozhi Wang et al. OncoTargets and Therapy
- H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
- (2017) Fei Peng et al. Cell Death & Disease
- Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance
- (2017) Sergei Boichuk et al. Oncology Letters
- The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer
- (2017) Akshay Malhotra et al. Oncotarget
- LncRNA UCA1 in anti-cancer drug resistance
- (2017) Haohao Wang et al. Oncotarget
- Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer
- (2017) Ali R. Özeş et al. Scientific Reports
- Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
- (2017) Jorge Gómez-Miragaya et al. Stem Cell Reports
- Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
- (2016) Le Qu et al. CANCER CELL
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
- (2016) Zhaolin Chen et al. CANCER LETTERS
- Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value
- (2016) Yi-Zhou Jiang et al. CANCER RESEARCH
- Non-cytochrome P450-mediated bioactivation and its toxicological relevance
- (2016) Jinping Gan et al. DRUG METABOLISM REVIEWS
- ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer
- (2016) Maryam Hosseini Hasanabady et al. JOURNAL OF BIOSCIENCES
- The bright side of dark matter: lncRNAs in cancer
- (2016) Joseph R. Evans et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences
- (2016) Delisha A. Stewart et al. JOURNAL OF PROTEOME RESEARCH
- CTC immune escape mediated by PD-L1
- (2016) Xuefei Wang et al. MEDICAL HYPOTHESES
- Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library
- (2016) Shiyou Zhu et al. NATURE BIOTECHNOLOGY
- Non-coding RNAs as drug targets
- (2016) Masayuki Matsui et al. NATURE REVIEWS DRUG DISCOVERY
- Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer
- (2016) Youyou Zhang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma
- (2016) Mansi A. Parasramka et al. PHARMACOLOGY & THERAPEUTICS
- Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
- (2016) Sai A. Balaji et al. PLoS One
- LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern
- (2016) T.-T. Sun et al. Cancer Discovery
- Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer
- (2016) Youyou Zhang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication
- (2016) Ji Wang et al. Oncotarget
- The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer
- (2016) Yinlong Yang et al. Oncotarget
- Long non-coding RNAs in anti-cancer drug resistance
- (2016) Qin-nan Chen et al. Oncotarget
- The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells
- (2016) Mark R. Pickard et al. Oncotarget
- The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis
- (2016) Tae Gyu Oh et al. EBioMedicine
- The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis
- (2016) Marissa Iden et al. PLoS One
- Differentiation of mammary tumors and reduction in metastasis uponMalat1lncRNA loss
- (2015) Gayatri Arun et al. GENES & DEVELOPMENT
- HOTAIR Long Noncoding RNA Promotes Gastric Cancer Metastasis through Suppression of Poly r(C)-Binding Protein (PCBP) 1
- (2015) Z.-Z. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- An overview of triple negative breast cancer for surgical oncologists
- (2015) Shiva Sharma et al. SURGICAL ONCOLOGY-OXFORD
- Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer
- (2015) Rui-Lei Liu et al. TUMOR BIOLOGY
- Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
- (2015) Xuan Zhou et al. Scientific Reports
- Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
- (2015) Kodappully Sivaraman Siveen et al. Oncotarget
- DEAD-box helicase DP103 defines metastatic potential of human breast cancers
- (2014) Eun Myoung Shin et al. JOURNAL OF CLINICAL INVESTIGATION
- lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
- (2014) Gabriel Eades et al. MOLECULAR CANCER RESEARCH
- Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
- (2014) Nagaraju Anreddy et al. MOLECULES
- Differential Expression of Enzymes Associated with Serine/Glycine Metabolism in Different Breast Cancer Subtypes
- (2014) Sang Kyum Kim et al. PLoS One
- MiR-7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway
- (2014) Hongyi Zhang et al. STEM CELLS
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- A novel long non-coding RNA-ARA: Adriamycin Resistance Associated
- (2013) Min Jiang et al. BIOCHEMICAL PHARMACOLOGY
- Long noncoding RNAs in innate and adaptive immunity
- (2013) Katherine A. Fitzgerald et al. CURRENT OPINION IN IMMUNOLOGY
- Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
- (2013) Kanjoormana A. Manu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Role of Glutathione in Cancer Progression and Chemoresistance
- (2013) Nicola Traverso et al. Oxidative Medicine and Cellular Longevity
- Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma
- (2012) J.-P. Gillet et al. CLINICAL CANCER RESEARCH
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation
- (2012) M. Jain et al. SCIENCE
- MicroRNA-21: A novel therapeutic target in human cancer
- (2011) Xuan Pan et al. CANCER BIOLOGY & THERAPY
- Long Intergenic Noncoding RNAs: New Links in Cancer Progression
- (2011) M.-C. Tsai et al. CANCER RESEARCH
- Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer
- (2011) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia
- (2011) J Dürig et al. LEUKEMIA
- Molecular Mechanisms of Long Noncoding RNAs
- (2011) Kevin C. Wang et al. MOLECULAR CELL
- Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
- (2011) Tiffany Hung et al. NATURE GENETICS
- The Long Noncoding RNA, Jpx, Is a Molecular Switch for X Chromosome Inactivation
- (2010) Di Tian et al. CELL
- Epigenetics of imprinted long non-coding RNAs
- (2010) Faizaan Mohammad et al. Epigenetics
- Iron-catalysed oxidation intermediates captured in a DNA repair dioxygenase
- (2010) Chengqi Yi et al. NATURE
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells
- (2010) Sabine Loewer et al. NATURE GENETICS
- Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
- (2010) M.-C. Tsai et al. SCIENCE
- Noncoding RNA Gas5 Is a Growth Arrest- and Starvation-Associated Repressor of the Glucocorticoid Receptor
- (2010) T. Kino et al. Science Signaling
- Regulatory roles of natural antisense transcripts
- (2009) Mohammad Ali Faghihi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Polycomb Proteins Targeted by a Short Repeat RNA to the Mouse X Chromosome
- (2008) J. Zhao et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search